期刊
BIOMED RESEARCH INTERNATIONAL
卷 2018, 期 -, 页码 -出版社
HINDAWI LTD
DOI: 10.1155/2018/8134902
关键词
-
资金
- Zhengzhou Science & Technology Basic Research Program [131PPTGG409-21]
Background. We aimed to investigate the effect and mechanism of curcumin (CUR) in Alzheimer's disease (AD). Methods. Mouse hippocampal neuronal cell line HT-22 was treated with A beta 1-42 and/or CUR, and then cell viability was evaluated by cell counting kit 8, Beclin-l level was detected using western blotting, and the formation of autophagosomes was observed by transmission electron microscopy (TEM). Furthermore, transcriptome sequencing and analysis were performed in cells with A beta 1-42 alone or A beta 1-42 + CUR. Results. A beta 1-42 treatment significantly inhibited cell viability compared with untreated cells (P < 0.01). After treatment for 48 h, CUR remarkably promoted cell viability compared with cell treated with A beta 1-42 alone (P < 0.01). Compared with cells treated with A beta 1-42 alone, the expression of Beclin-1 was slightly reduced in cells with combined treatment of A beta 1-42 with CUR (P < 0.05). Consistently, TEM results showed that CUR inhibited the formation of autophagosomes in cells treated with A beta 1-42. Furthermore, the protein-protein interaction network showed five key genes, including MYC, Cdh1, Acaca, Egr1, and CCnd1, likely involved in CUR effects. Conclusions. CUR might have a potential neuroprotective effect by promoting cell viability in AD, which might be associated with cell autophagy. Furthermore, MYC, Cdh1, and Acaca might be involved in the progression of AD.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据